Compounds with high Z-scores were inhibitors of Bp K96243 induced MNGC formation, whereas compounds with low Z-scores increased MNGC formation. Compounds that had a percentage of MNGC Z-score >3 were scored as positive hits. A total of 15 out of the original 43 compounds matched this criterion (Figure  5B). Furthermore, to exclude cytotoxicity as the leading mechanism of action for MNGC reduction, compounds that had a Number of Nuclei Z-score < - 3 were not considered for further analysis. Veliparib A total of 9 out of the original 15 compounds passed the cytotoxicity filter (Figure  5B) and were considered as hits. A total of 7 out of

the 9 identified hits belong to the Histone Deacetylase (HDAC) enzyme inhibitor category. Importantly, none of these hit compounds reduced the total number of Bp spots per well (Data not shown), ruling out that their mechanism of action involves direct inhibition of bacterial adhesion and/or uptake by host cells. Visual inspection of samples treated with the three HDAC inhibitors (Scriptaid, Fluoro-SAHA,

and M-344) confirmed that these compounds were not cytotoxic and hence did not alter the cell number when compared to DMSO treated samples, but substantially inhibited MNGC formation in Ro 61-8048 purchase their presence. Furthermore, M-344 showed a dose-dependent inhibition of MNGC formation induced upon Bp K96243 infection (Figure  5C). Altogether, these results indicate that the HCI MNGC assay can be used to screen small molecule libraries for the identification of compounds that can inhibit MNGC formation and that one or more HDAC’s might be involved in the positive regulation

of this process. Figure 5 Screening of focused small molecule library for Bay 11-7085 inhibitors of MNGC formation. RAW264.7 macrophages were pretreated for 2 h with a collection of 43 compounds active against enzymes involved in epigenetics regulation at a concentration of 20 μM and then infected with 30 MOI of Bp K96243 for 8 h. Cells were fixed, stained in IF and imaged as described above. The effect of the tested compounds on MNGC formation was quantified. Compounds were ranked based on the potency of MNGC inhibition when compared to DMSO-treated, Bp K96243-infected samples (Negative control). Cytotoxic (Number of Nuclei Z-score < -3) were not further considered. (A) Representative confocal images of macrophages pre-treated with DMSO control or primary hit compounds active in the MNGC screen. Scale bar: 90 μm. (B) Compounds that significantly reduced the number of MNGC when compared to DMSO treated samples (% MNGC Z-score > 3) were scored as positive hits (red bars). Bars represent means from two replicates. (C) Dose-dependent inhibition of MNGC formation by compound M-344 identified in the primary screen. AZ 628 Conclusions In summary, we have successfully developed an automated HCI assay to quantitate MNGCs induced by Bp in macrophages.